Cite

HARVARD Citation

    Biswas, K. et al. (2020). RAD52 S346X variant reduces breast cancer risk in BRCA2 mutation carriers. Molecular oncology. 14 (6), pp. 1121-1123. [Online]. 
  
Back to record